Venus Research Center
Cairo, Egypt
NCT Number: NCT07296562
This study is a Delphi-based expert consensus project aimed at developing evidence-informed recommendations for the safe and effective use of nutriceuticals during pregnancy. Despite widespread use of vitamins, minerals, and other dietary supplements in prenatal care, significant variability exists in clinical practice regarding indications, dosing, timing, and safety monitoring.
Interested in participating?
Request Info25 year and older
All sexes
Observational
Cairo, Egypt
This study is a non-interventional, methodological Delphi consensus project designed to develop standardized recommendations for the use of nutriceuticals during pregnancy. Nutriceuticals, including vitamins, minerals, antioxidants, omega-3 fatty acids, and herbal supplements, are commonly used to support maternal health and fetal development. However, evidence regarding optimal dosing, timing, and safety profiles is inconsistent, and practice patterns vary globally.
A steering committee of experts in obstetrics, maternal-fetal medicine, and clinical nutrition will conduct a thorough literature review and draft initial statements addressing key domains:
Indications for nutriceutical use (routine supplementation, deficiency prevention, high-risk pregnancies)
Recommended dosing and timing for common nutriceuticals (folic acid, iron, vitamin D, iodine, omega-3 fatty acids, etc.)
Safety considerations and contraindications (including herbal and non-standard supplements)
Monitoring strategies for maternal and fetal safety
Integration with dietary and lifestyle interventions
Counseling and patient education
A panel of experts in obstetrics and maternal nutrition will participate in multiple Delphi rounds. Panelists will rate each statement on a Likert scale for agreement. After each round, anonymized feedback will be provided, and statements not reaching the predefined consensus threshold (e.g., ≥70-80%) will be revised for subsequent evaluation.
The final output will consist of consensus-based recommendations for nutriceutical use in pregnancy, highlighting areas of strong agreement, areas of uncertainty, and research priorities. These recommendations aim to support safe, evidence-informed clinical practice for maternal and fetal health.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Active involvement in prenatal care and experience or knowledge in nutriceutical use during pregnancy.
Engagement in clinical teaching, research, guideline development, or professional society activities related to maternal health or nutrition.
Willingness and availability to participate in all Delphi rounds.
Provision of informed consent to participate.
Exclusion criteria
Less than 5 years of relevant clinical experience.
Limited or no experience with nutriceutical counseling/prescribing in pregnancy.
Significant undisclosed conflict of interest related to nutriceutical products.
Inability or unwillingness to participate in all Delphi rounds.
Time frame: 6-12 weeks
Level of expert consensus on statements regarding nutraceutical use in pregnancy, measured as the proportion of panelists reaching the predefined agreement threshold (e.g., ≥70-80%) for each statement across Delphi rounds.
Time frame: 6-12 weeks
Consensus on indications for specific nutriceuticals (e.g., folic acid, iron, vitamin D, omega-3 fatty acids, iodine, herbal supplements).
Consensus on optimal dosing, timing, and duration of supplementation.
Consensus on safety monitoring protocols, including laboratory assessments and maternal/fetal surveillance.
Consensus on contraindications and risk mitigation strategies for nutriceutical use.
Consensus on integration with dietary and lifestyle interventions.
Identification of areas of uncertainty requiring further research.
Venus Research Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07147972
Brain Diseases, Central Nervous System Diseases
View Trial DetailsNCT06274385
Nutraceuticals
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05503927
Body Weight, Nutrition Disorders
Ann Arbor, Michigan, United States
View Trial DetailsNCT07461428
Breastfeeding Education, Healthy
Ankara, Esenboğa, Turkey (Türkiye)
View Trial Details